Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
35.42
+0.24 (+0.68%)
Official Closing Price
Updated: 4:15 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
29
30
Next >
Top 3 Health Care Stocks That Could Blast Off This Quarter
↗
January 22, 2025
Via
Benzinga
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
↗
January 17, 2025
Via
The Motley Fool
We Asked Retail How Viking Therapeutics Can Restore Investor Confidence: Majority Say Pursue Buyout Talks
↗
January 15, 2025
Oppenheimer earlier this month listed Viking as one of five biotech companies that could be prime candidates for an "aspirational" takeover.
Via
Stocktwits
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
↗
January 14, 2025
Via
The Motley Fool
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
↗
January 09, 2025
Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Government
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
↗
December 30, 2024
Via
Benzinga
Looking Into Viking Therapeutics's Recent Short Interest
↗
December 20, 2024
Via
Benzinga
Earnings Scheduled For February 5, 2025
↗
February 05, 2025
Via
Benzinga
This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?
↗
February 02, 2025
Wall Street has high hopes for development-stage pharmaceutical company Viking Therapeutics.
Via
The Motley Fool
Jim Cramer: This Industrial Stock Is 'Absolutely Terrific', First Solar Is 'Very Inexpensive'
↗
January 29, 2025
First Solar will report financial results for the fourth quarter and full year ended Dec. 31, 2024, after the closing bell on Tuesday, Feb. 25, 2025.
Via
Benzinga
(VKTX) - Analyzing Viking Therapeutics's Short Interest
↗
January 28, 2025
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 27, 2025
Via
Benzinga
Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results
↗
January 24, 2025
The Danish drug giant reported a 22% weight loss over 36 weeks.
Via
Investor's Business Daily
This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?
↗
January 22, 2025
Via
The Motley Fool
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
↗
January 16, 2025
Via
Benzinga
3 Mid-Cap Stocks That Could Take Off in 2025
↗
January 09, 2025
Via
The Motley Fool
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
↗
January 06, 2025
JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.
Via
Benzinga
1 Under-the-Radar Stock to Buy Before It Soars by 156%, According to Select Wall Street Analysts
↗
January 06, 2025
This is a high-risk, high-reward stock.
Via
The Motley Fool
Why Viking Therapeutics Stock Plummeted by 24% in December
↗
January 04, 2025
Via
The Motley Fool
Should You Buy the Dip on This High-Flying Stock?
↗
January 03, 2025
Via
The Motley Fool
StoryTrading's Secrets To January Gains - Don’t Miss These Picks
↗
January 02, 2025
As we usher in the new year, market dynamics continue to be shaped by a blend of tax-deferral selling, the January effect, and macro uncertainties.
Via
Talk Markets
Topics
Stocks / Equities
3 Stocks That Could Be Monster Winners in 2025
↗
December 29, 2024
Via
The Motley Fool
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
↗
December 21, 2024
Via
The Motley Fool
My Top 10 Stocks to Buy for 2025
↗
December 21, 2024
Via
The Motley Fool
Why Viking Therapeutics Tumbled by More Than 10% This Week
↗
December 20, 2024
Via
The Motley Fool
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
↗
December 20, 2024
Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for.
Via
The Motley Fool
Stock Market Tumbles, Treasury Yields Soar On Fed Rate Outlook: Weekly Review
↗
December 20, 2024
Micron, Vertex, Novo Nordisk and Nike were notable losers on news.
Via
Investor's Business Daily
Topics
Economy
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
↗
December 20, 2024
Eli Lilly and Viking Therapeutics jumped on Novo's setback.
Via
Investor's Business Daily
From Powell To Profits: Strategic Stock Picks Amid Market Uncertainty
↗
December 19, 2024
Yesterday's market movement aligned perfectly with expectations, as the FOMC meeting drove significant volatility.
Via
Talk Markets
Topics
Stocks / Equities
What's Going On With Viking Therapeutics Stock On Wednesday?
↗
December 18, 2024
Merck partners with Hansoh Pharma for GLP-1 drug development, while analysts highlight Viking's obesity assets as key for future growth.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
